Pfizer’s Lyme Vaccine Clears Phase 2 — Regulatory Path Is Next
Pfizer and Valneva’s Lyme Vaccine Shows Durable Immune Response, But the Harder Work Begins Now Daily Signal — March 23, 2026 TL;DR: Pfizer and…
Category
Industry & Business
Capital flows, acquisitions, platform wars, enterprise adoption, and competitive strategy shaping the AI economy.
117 results in this archive
Meta Eyes Its Deepest Cuts as AI Spending Doubles
Meta Eyes Its Deepest Cuts as AI Spending Doubles Daily Signal — March 15, 2026 TL;DR: Meta is reportedly planning layoffs that could eliminate…
xAI’s Structural Collapse Reveals Coding Tool Gap
xAI Admits a False Start: Co-Founder Exodus and a Coding Tool Reckoning Daily Signal — March 14, 2026 TL;DR: Elon Musk’s xAI has acknowledged…
Wonderful’s $2B Agent Bet Anchors an Uneven AI Day
Enterprise AI Agents Draw $2B Valuation as Security and Infrastructure Questions Quietly Mount Daily Signal — March 12, 2026 TL;DR: Wonderful’s $150M Series B…
Agentic Procurement Arrives With $30M Mandate
Agentic Procurement Arrives With a $30M Mandate Daily Signal — March 5, 2026 TL;DR: Lio closed a $30 million Series A led by Andreessen…
Algorithmic Influence, Infrastructure Fragility, and a $4M Bet on…
Algorithmic Influence, Infrastructure Fragility, and a $4M Bet on Creator Scale Daily Signal — March 2, 2026 TL;DR: Devotion, a creator economy marketing platform…
The Weight of the Machine: AI Infrastructure, Capital, and the Alignment Question in 2026
A data-driven pillar on where AI actually stands in 2026 — the economics of scale, the physics of compute, the fracturing of regulatory consensus, and what all of it means for builders working at the edge of the stack.
OpenAI Raises $110B as Amazon Partnership Reshapes AI Infrastructure
OpenAI at $840B: The Infrastructure Consolidation Behind the Capital Daily Signal — February 27, 2026 TL;DR: OpenAI closed a $110 billion funding round led…
Why Temperature Zero Exists: A Founding Statement
Temperature Zero is an independent AI and technology publication built by a builder. We cover artificial intelligence, automation, infrastructure, defense, biotech, and policy — with clarity, context, and consequence. No hype required. Just analysis from someone using the tools he's writing about.